Expanding access. Advancing cures.
bringing innovation through cellular therapy closer to you
Our Services
Cellular Therapy is here and Cellserve is the answer!
Cell therapy is carved in the future of all medicine.
Today, commercial cellular therapy products are offered by less than 5% of health care centers in the United States and are mostly academic medical centers. The demand for cellular therapy is continuously increasing and exceeds the demand. Our goal is to make cellular therapy more accessible in the United States and globally. Our plan is to identify, train, and support eligible healthcare centers to effectively deliver cellular therapy, while also assisting existing programs with their expansion, growth, and restructuring.
We believe that bringing high quality health care closer to the patient will promote and maximize compliance, continuity of care, and patient satisfaction.
Consultation and Training
We offer the specialized expertise that is essential to a safe and successful Cellular Therapy Program, covering the operational, quality, and regulatory areas for your practice.
Tools
Innovation
cellserve
What is Cellular Therapy?
Cellular therapy is the administration of cells as a "living drug" to treat disease.
Cellular therapy is the administration of cells that frequently undergo genetic engineering to treat disease. Often considered a “living drug”, these cells work with the immune system, and for that reason, cellular therapy is considered a form of immunotherapy.
Immunotherapy is a treatment that harnesses the power of the immune system to fight disease. One of the most common forms of cellular therapy is stem cell transplantation, where blood-forming stem cells are infused to treat patients with blood cancers such as leukemia or lymphoma.
cellserve
Why cellular therapy matters.
Cellserve supports eligible healthcare centers in building and advancing cell therapy programs and clinical research platforms.
Access to CAR T-cell therapy is limited primarily to university-affiliated academic hospitals, representing only about 3% of centers in the U.S. This fails to meet patient demand today and is insufficient to accommodate the significant projected growth.
The expansion of cellular therapy to community centers with the right infrastructure is imperative and profitable.
Let us help you be one of them!
About us
Testimonials
Physician Hospitalist
Nurse Practitioner
Daniel Couriel, MD, MS, MBA
CAR T- Cell Patient
by the nerds o